SEC Form 4 · accession 0001179110-15-008722
OSIRIS THERAPEUTICS, INC. · OSIR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Philip R Jacoby Jr.
Officer — Chief Financial Officer
Period of report
May 27, 2015
Accepted (ET)
May 29, 2015 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001360886
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 27, 2015 | M | 11,389 | $7.74 | A | 23,889 | D | |
| Common Stock | May 27, 2015 | M | 3,751 | $6.46 | A | 27,640 | D | |
| Common Stock | May 27, 2015 | M | 4,860 | $7.13 | A | 32,500 | D | |
| Common Stock | May 27, 2015 | S | 20,000 | $18.554 | D | 12,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy) | $7.74 | May 27, 2015 | M | 11,389 | D | Mar 12, 2013 | Mar 12, 2020 | Common Stock | 11,389 | 67,792 | D |
| Incentive Stock Option (right to buy) | $6.46 | May 27, 2015 | M | 3,751 | D | May 27, 2013 | May 27, 2020 | Common Stock | 3,751 | 64,041 | D |
| Incentive Stock Option (right to buy) | $7.13 | May 27, 2015 | M | 4,860 | D | Feb 14, 2013 | Feb 14, 2021 | Common Stock | 4,860 | 59,181 | D |